Escherichia coli and Bacteroidesfragilis are common copathogens in clinical intra-abdominal sepsis, yet it is unclear how they interact synergistically in vivo. We sought to determine whether E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis. Our data indicated that nonviable E. coli (018ab:K56/K7:-and 0111:B4), Klebsiella pneumoniae, B. fragilis, and Bacteroides thetaiotaomicron were handled in a similar fashion by both host defenses of the peritoneal cavity. The use of 2 x 108 nonviable radiolabeled E. coli as a tracer and either 2 x 109 B. fragilis or 2 x 109 E. coli (either viable or nonviable) as a competing agent to inhibit host defenses demonstrated that although clearance and phagocytosis could be inhibited, the inhibition occurred to a similar degree with either E. coli or B. fragilis. Thus, B. fragilis did not compete to any greater extent than E. coli did for peritoneal clearance or opsonization and phagocytosis in vivo. These data indicate that bacterial synergy probably does not occur on the basis of reduced peritoneal clearance or by a reduction in the opsonization and phagocytosis of either organism by the copathogen. These results provide indirect support for the hypothesis that in bacterial synergy, one organism directly stimulates the growth of the other, perhaps by providing a growth factor.
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Escherichia coli and Bacteroides fragilis are common copathogens in clinical intra-abdominal sepsis (2, 9) . On the basis of several experimental studies, these two organisms have been postulated to act synergistically, leading to either enhanced mortality (7) or increased abscess formation (7, 17, 18) . Although several hypotheses have been put forth to explain this phenomenon, the mechanism by which it occurs remains obscure. Only a single previous study by Reznikov et al. (19) has attempted to assess the in vivo effect of these organisms on intraperitoneal host defense. These authors found no alteration in bacterial counts when both organisms were injected intraperitoneally (i.p.) compared with either organism alone. Several publications, however, have provided in vitro data that support the hypothesis that anaerobic bacteria exert a detrimental effect on the opsonization, phagocytosis, and killing of aerobic bacteria and have implied that this may be operative in vivo (11, 12, 16, 20) . The purpose of the present study was to reassess the interaction of E. coli and B. fragilis with peritoneal host defense in an in vivo model. It is well known that bacteria are readily removed from the peritoneal cavity into the bloodstream by host peritoneal translymphatic absorption and that concomitant uptake into autochthonous phagocytic cells takes place during peritoneal contamination. We therefore sought to compare and contrast the effects of E. coli and B. fragilis alone and in combination on in vivo rat peritoneal host defenses to determine whether impairment of these defenses occurs, thus providing an explanation for the synergistic interaction of these organisms which has been described in some models. has been repeatedly used in previous studies from this laboratory (1, (5) (6) (7) (8) exception that growth took place in the anaerobic chamber in supplemented brain heart infusion medium (0.5 ml of iododeoxyuridine per 19.5 ml of brain heart infusion medium). A sample of each bacterial suspension was obtained, serial dilutions were performed, pour or surface plates were made, and exact quantitation was established by enumerating the developed colonies. The remainder of the culture was subjected to centrifugation, after which resuspension in a volume of 10% Formalin equal to the volume of the initial culture took place. Formalin killing of the radiolabeled bacteria was allowed to proceed for 20 min, after which the bacterial suspension was subjected to two further cycles of centrifugation. The first cycle was followed by resuspension in 10% Formalin, and the next cycle was followed by resuspension in a volume of 0.9% saline equal to that of the initial bacterial suspension. 6 h, and at 1-h intervals up to 8 h after bacterial challenge animals were rapidly asphyxiated in a CO2 chamber, and 10 ml of sterile saline was injected i.p. The animals were agitated for 1 min to ensure adequate mixing of the peritoneal contents, and a midline laparotomy was performed. Four 1-ml samples of peritoneal fluid were obtained, and the amount of radioactivity was directly determined. Immediately after injection, >95% of the radiolabel was recoverable in all cases from the peritoneal fluid sample. The remaining two samples were collected in glass tubes containing EDTA at 4°C and were subjected to three cycles of low-speed centrifugation (160 x g for 10 min), and after each cycle the samples were resuspended in 0.9% saline. This procedure has been demonstrated to be effective for separating leukocytes from other contaminants and bacteria that remain in the supernatant (22) . The amount of leukocyte-associated radioactivity in each sample was then determined. Control experiments in which rat peritoneal leukocytes and E. coli or B. fragilis were combined in vitro in glass tubes containing EDTA at 4°C demonstrated no significant radioactivity in the leukocyte pellet, and bacterial radiolabel did not sediment during the low-speed centrifugation steps. Punch biopsy specimens (3 mm in diameter) of the rat parietal peritoneum were obtained and washed with saline three times before gamma counting. No significant adherence of either radiolabeled E. coli or B. fragilis (<107) occurred at any time up to 8 h after bacterial challenge.
MATERIALS AND METHODS
Statistics. Clearance and phagocytosis data were assessed by a two-tailed Student t test and standard tables.
RESULTS
Removal of 2 x 108 nonviable E. coli from the rat peritoneal cavity. By 1 h, 1.38 ± 0.18 x 10' E. coli were removed from the peritoneal cavity (Fig. 1) . Peritoneal leukocyte association with E. coli was rapid, with over 6.30 ± 1.70 x 107 bacteria being phagocytized by 20 min. After 20 min, the number of both total bacteria and leukocyte-associated bacteria steadily declined, and by 8 h, 1.20 ± 0.48 x 107 E. coli remained. No significant difference was noted in the clearance or leukocyte uptake of E. coli that had been either Formalin or heat killed (P > 0.1, data not shown).
Removal of 2 x 108 radiolabeled nonviable B. fragilis from the peritoneal cavity. B. fragilis was removed from the peritoneal cavity in a fashion similar to that of nonviable E. coli (Fig. 2) competing factor led to similar competition when the total clearance and the leukocyte uptake of radiolabel were compared with those from the experiments described above, in which nonviable bacteria were utilized (P > 0.1).
DISCUSSION
Although bacterial synergism has been defined as the ability of two or more microbes to act in concert to produce a more severe infection than that which occurs with either pathogen alone, the phenomenon is poorly understood clinically or experimentally. Meleney et al. (15) and Altemeier (4) noted synergism among aerobic anaerobic microbial participants in intra-abdominal sepsis and were able to reproduce this synergism in experimental models. Weinstein and colleagues (23) have described an animal model in which gelatin capsules containing barium sulfate and the pooled colonic contents of rats were implanted in the peritoneal cavities of rats; this demonstrated a synergistic interaction between aerobes and anaerobes in terms of abscess formation. Onderdonk et al. (18) showed that E. coli, enterococci, and B. fragilis predominated during an early stage of peritonitis in this model and that blood cultures were uniformly positive (usually for E. coli) during that stage. The abscesses that formed later in surviving animals contained primarily B. fragilis and Fusobacterium sp. These same investigators (17) implanted pure and mixed cultures of E. coli, enterococci, B. fragilis, or F. varium into the peritoneal cavities of rats. They noted that significant mortality was present only in those animals receiving E. coli, but the combination of an anaerobe with a facultative organism was required for increased abscess formation. Kelly (13) demonstrated that E. coli and B. fragilis injected subcutaneously into guinea pigs would produce a more severe soft tissue infection than either organism alone does. This work demonstrated that a critical minimal inoculum size was required for either organism to synergize with the other; it also provided evidence that synergy was correlated with the growth of both microorganisms in the subcutaneous tissue. We have previously demonstrated that E. coli and B. fragilis act synergistically in the rat peritoneal cavity, leading to both enhanced abscess formation and mortality when implanted in a fibrin clot matrix, and that the effect is critically dependent on the initial inoculum size (7) .
A number of mechanisms by which synergy between aerobic and anaerobic organisms occurs have been demonstrated in experimental models. One organism may: (i) provide necessary nutrients for another (14) ; (ii) create a suitable environment for another (e.g., E. coli lowering the redox potential of the media, thereby permitting B. fragilis to grow) (14) ; or (iii) protect another organism from natural host defenses (11, 12, 16, 20) . For example, B. fragilis has been shown to reduce the opsonization and phagocytosis of E. coli in vitro, presumably because of competition for opsonins (20) . Evidence has also been provided indicating that B. fragilis may diminish the in vitro phagocytosis (12) , chemiluminescence (16) , or intracellular killing (11, 12, 16) of facultative aerobes such as P. mirabilis, although this also has not been demonstrated in vivo. Despite the plethora of in vitro studies in which a mechanism has been sought to explain how E. coli and B. fragilis interact, only one previous study has directly addressed this problem in vivo (19) . These investigators noted that simultaneous i.p. infection with E. coli and B. fragilis, compared with either organism alone, did not lead to the enhanced growth of either organism on the basis of viability counts.
The present study sought to determine whether both E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis, thus accounting for the synergistic interaction demonstrated in some models. To examine the interactions of host peritoneal defenses with invading microorganisms, the clearance from the peritoneal cavity and the host phagocyte uptake of either E. coli or B. fragilis were first examined. A 10-fold larger number of either E. coli or B. fragilis without radiolabel was then injected simultaneously with 2 x 108 radiolabeled E. coli, and the clearance and host phagocyte uptake of radiolabeled tracer were measured to test the hypothesis that B. fragilis significantly inhibits the peritoneal host removal mechanisms for E. coli. Previous anatomic studies have demonstrated that particulate material in the peritoneal cavity is rapidly removed via specialized diaphragmatic pores (stomata) that drain into lymphatic lacunae (3, 21) . We have previously demonstrated the rapidity by which E. coli particulates are removed into the bloodstream from the peritoneal cavity of the rat (5 
